Phreesia, a healthcare SaaS company, is facing a class action lawsuit from investors who bought its stock between May 2025 and March 2026. The lawsuit alleges Phreesia misled investors by not disclosing weakening pharmaceutical marketing commitments and reduced visibility into future spending within its Network Solutions segment. In March 2026, Phreesia lowered its fiscal 2027 revenue forecast from $545-$559 million to $510-$520 million, citing lower client spending and increased variability in revenue forecasting. Following this, the stock price dropped about 27%. Investors may participate in the class action, with a lead plaintiff deadline of July 13, 2026.
Shirofune has introduced Walmart Connect, an integration that allows advertisers and agencies to manage Walmart retail media campaigns alongside other digital channels within a single platform. This automation reduces manual bid adjustments and repor...
Purecore Metals Inc. has signed a non-binding letter of intent with Skyharbour Resources to acquire an option to earn up to 100% interest in the Yurchison uranium property in Saskatchewan's Athabasca Basin. The property covers over 35,000 hectares an...
Point completed a $508.6 million rated asset-backed securitization of its Home Equity Investment (HEI) assets, marking the largest transaction ever in the HEI asset class. The deal attracted over 30 institutional investors and priced at significantly...
The global reactive hot melt adhesives market is projected to grow from $2.02 billion in 2025 to $4.29 billion by 2035, at a CAGR of 7.72%. Growth is driven by regulations limiting solvent-based adhesives, increased use of polyurethane adhesives in a...
Cardano has introduced native support for BLS12-381 elliptic curve cryptography in its Plutus smart contracts, enabling the verification of thousands of signatures on-chain at a low and predictable cost. This technology compresses multiple signatures...
